David T. Hung,Andrew Asher Protter,Sarvajit Chakravarty,Rajendra Parasmal Jain
申请号：
US14033234
公开号：
US09051314B2
申请日:
2013.09.20
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This disclosure relates to new compounds that may be used to modulate a histamine receptor in an individual. Novel compounds are described, including new bridged heterocyclic [4,3-b]indole compounds. Pharmaceutical compositions are also provided. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
